Package 61958-1201-1

{"route": ["ORAL"], "spl_id": "65c2d2eb-d180-41c3-b346-9cdc6e52d5ed", "openfda": {"nui": ["N0000190114", "N0000191001", "N0000185503", "N0000182137", "N0000190107", "N0000190108", "N0000190113", "N0000191423", "N0000000127", "N0000175887", "N0000185507", "N0000175462", "M0015066", "N0000009947"], "unii": ["LW2E03M5PG", "4GDQ854U53", "G70B4ETF4S", "OTT9J7900I"], "rxcui": ["1306292", "1306298"], "spl_set_id": ["74ae2a93-b267-444c-8f0f-a2a6522260ee"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "HIV Integrase Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-1201-1)", "package_ndc": "61958-1201-1", "marketing_start_date": "20120827"}], "brand_name": "Stribild", "product_id": "61958-1201_65c2d2eb-d180-41c3-b346-9cdc6e52d5ed", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitor [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Integrase Inhibitors [MoA]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "61958-1201", "generic_name": "elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Stribild", "active_ingredients": [{"name": "COBICISTAT", "strength": "150 mg/1"}, {"name": "ELVITEGRAVIR", "strength": "150 mg/1"}, {"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "NDA203100", "marketing_category": "NDA", "marketing_start_date": "20120827", "listing_expiration_date": "20261231"}